Science behind "increasing gap between two Covishield vaccine doses to 12-16 weeks Medha Baranwal13 May 2021 11:45 AM ISTIndia: A government panel has suggested increasing the gap between two doses of the Covishield COVID-19 vaccine to 12-16 weeks. However, no such...
Guided antiplatelet therapy efficacious and safe in percutaneous coronary intervention:Lancet Dr Satabdi Saha26 April 2021 9:47 AM ISTAccording to recent research reports published in The Lancet,Guided selection of antiplatelet therapy improved both composite and individual...
Rituximab treatment may increase ICU admissions, mortality in COVID-19 patients: Study Medha Baranwal24 April 2021 4:31 AM ISTFrance: The administration of rituximab in patients with inflammatory rheumatic and musculoskeletal diseases is associated with more severe COVID-19...
Injectable antipsychotics better than oral ones at preventing relapse in schizophrenia: Lancet Dr Satabdi Saha21 April 2021 8:30 AM ISTIn a recent development, researchers have noted that, among long-acting injectable antipsychotics (LAIs) and oral antipsychotics in managing...
Evidence supporting airborne transmission of Coronavirus overwhelming: Lancet Hina Zahid18 April 2021 2:26 PM ISTThere is consistent, strong evidence that the SARS-CoV-2 virus, which causes COVID-19, is predominantly transmitted through the air, according to a...
Longer delay of RRT does no good for critically ill severe AKI patients: Study Medha Baranwal16 April 2021 7:15 AM ISTFrance: Longer postponement of renal replacement therapy (RRT) did not confer any additional benefit and is indeed harmful in critically ill patients...
Patients with previous COVID-19, at 84 percent lower risk of reinfection: Lancet Medha Baranwal15 April 2021 7:45 AM ISTUK: A previous history of COVID-19 cuts the risk of reinfection by 84% and also lowers the risk of symptomatic infection during 7 months of follow-up...
Two -week benznidazole in Chagas disease as good as current eight-week regimen: Lancet Dr Satabdi Saha14 April 2021 6:45 PM ISTBenznidazole induced effective antiparasitic response, regardless of treatment duration, dose, or combination with fosravuconazole, and was well...
COVID-19 linked to increased cases of cardiac arrests: Study Medha Baranwal8 April 2021 9:36 PM ISTUSA: A recent study has found a dramatic increase in out-of-hospital cardiac arrests (OHCAs) in early 2020 paralleling the local prevalence of...
Delaying 2nd Oxford COVID-19 vaccine dose may boost efficacy: Lancet Medha Baranwal24 Feb 2021 11:21 AM ISTUK: A 3-month interval between versus 6-week interval between Oxford COVID-19 vaccine results in higher vaccine efficacy, finds a recent study in the...
CPPF after CABG reduces bleeding and related complications: Lancet Medha Baranwal16 Feb 2021 6:44 PM ISTNetherlands: The continuous postoperative pericardial flushing (CPPF) therapy reduced bleeding and bleeding related complications in patients who have...
Posaconazole as good as voriconazole for treatment of invasive aspergillosis: Lancet Medha Baranwal12 Feb 2021 10:30 AM ISTDelhi: Posaconazole can be used as a first-line treatment for people with invasive aspergillosis, finds a recent study in the journal Lancet....
